Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CloDiCHI: C. difficile Controlled Human Infection Model
NCT06702345Phase 1Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in Clostridioides difficile infection (CDI) (3 cohorts), sponsored by Leiden University Medical Center. Primary endpoints: Safety of exposure to toxigenic C. difficile spores, Colonisation with the challenge C. difficile strain and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT06702345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702345.